These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31606803)

  • 1. Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia.
    Borovskaya TG; Kamalova SI; Grigor'eva VA; Poluektova ME; Vychuzhanina AV; Kuchin AV; Chukicheva IY; Buravlev EV; Fomina TI; Plotnikov MB; Goldberg VE; Dygai AM
    Bull Exp Biol Med; 2019 Sep; 167(5):606-609. PubMed ID: 31606803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroquercetin effects on the morphology and antioxidant/prooxidant balance of the prostate in rats with sulpiride-induced benign hyperplasia.
    Borovskaya TG; Krivova NA; Zaeva OB; Fomina TI; Kamalova SI; Poluektova ME; Vychuzhanina AV; Shchemerova YA; Grigor'eva VA; Goldberg VE; Plotnikov MB
    Bull Exp Biol Med; 2015 Feb; 158(4):513-6. PubMed ID: 25708337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological Assessment of Prostatotropic Activity of (3,5-Dimethyl-4-Hydroxy)Benzyl Thiododecane on a Model of Benign Prostatic Hyperplasia in Rats.
    Nizomov SA; Sorokina IV; Zhukova NA; Tolstikova TG; Semenov DE; Prosenko AE
    Bull Exp Biol Med; 2019 Oct; 167(6):809-812. PubMed ID: 31656010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and Biochemical Characteristics of Prostate Hyperplasia during Sulpiride Treatment.
    Tsvetkov IS; Kosyreva AM; Mkhitarov VA; Postovalova EA; Khochanskiy DN; Makarova OV; Bredova OY; Ostrov VF
    Bull Exp Biol Med; 2020 Feb; 168(4):533-537. PubMed ID: 32152847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of sulpiride model of benign prostatic hyperplasia for evaluation of the effectiveness of drug therapy.
    Borovskaja TG; Sergeeva SA; Udut VV; Fomina TI; Jurmazov ZA; Pahomova AV; Poluektova ME; Chemerova JA; Rumpel' OA
    Bull Exp Biol Med; 2011 Sep; 151(5):588-92. PubMed ID: 22462052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.
    Cordaro M; Impellizzeri D; Siracusa R; Gugliandolo E; Fusco R; Inferrera A; Esposito E; Di Paola R; Cuzzocrea S
    Toxicol Appl Pharmacol; 2017 Aug; 329():231-240. PubMed ID: 28610993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatotropic Action of Glycyrrhizic Acid Disodium Salt in Benign Prostatic Hyperplasia Models.
    Nizomov SA; Sorokina IV; Zhukova NA; Borisov SA; Tolstikova TG; Semenov DE; Bakarev MA
    Bull Exp Biol Med; 2020 May; 169(1):114-118. PubMed ID: 32488776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
    El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
    Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
    Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
    BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of biologically active substances of animal and plant origin on prooxidant-antioxidant balance in rats with experimental prostatic hyperplasia].
    Belostotskaia LI; Nikitchenko IuV; Gomon ON; Chaĭka LA; Bondar' VV; Dziuba VN
    Eksp Klin Farmakol; 2006; 69(4):66-8. PubMed ID: 16995443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
    Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
    Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
    Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
    J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical evaluation of naftopidil enantiomers: Rat functional assays in vitro and estrogen/androgen induced rat benign prostatic hyperplasia model in vivo.
    Huang JJ; Cai Y; Yi YZ; Huang MY; Zhu L; He F; Liu XW; Huang BY; Yuan M
    Eur J Pharmacol; 2016 Nov; 791():473-481. PubMed ID: 27615445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
    Rick FG; Szalontay L; Schally AV; Block NL; Nadji M; Szepeshazi K; Vidaurre I; Zarandi M; Kovacs M; Rekasi Z
    J Urol; 2012 Apr; 187(4):1498-504. PubMed ID: 22341819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
    Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ
    J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats.
    Wu JH; Jiang XR; Liu GM; Liu XY; He GL; Sun ZY
    Toxicol Ind Health; 2011 Oct; 27(9):810-9. PubMed ID: 21415097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of pharmacological activity of afala on the model of hormone-induced prostatitis in rats.
    Savelieva KV; Borovskaya TG; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI
    Bull Exp Biol Med; 2007 Nov; 144(5):699-701. PubMed ID: 18683500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the phytoestrogenic, pro-apoptotic and anti-oxidative properties of silymarin in inhibiting experimental benign prostatic hyperplasia in rats.
    Atawia RT; Tadros MG; Khalifa AE; Mosli HA; Abdel-Naim AB
    Toxicol Lett; 2013 May; 219(2):160-9. PubMed ID: 23500659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the efficiency of prostatotropic agents of natural origin in experimental benign prostatic hyperplasia.
    Borovskaya TG; Fomina TI; Ermolaeva LA; Vychuzhanina AV; Pakhomova AV; Poluektova ME; Shchemerova YA
    Bull Exp Biol Med; 2013 May; 155(1):67-70. PubMed ID: 23667874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory Activities of Phenolic Compounds Isolated from Adina rubella Leaves Against 5α-Reductase Associated with Benign Prostatic Hypertrophy.
    Yin J; Heo JH; Hwang YJ; Le TT; Lee MW
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27399661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.